Anthony Stell

Dr. Anthony Stell

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2018 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
YAYaxin An
Yaxin An
MRManja Reimann
Manja Reimann
JMJimmy Masjkur
Jimmy Masjkur
KLKatharina Langton
Katharina Langton
MPMirko Peitzsch
Mirko Peitzsch
GEGraeme Eisenhofer
Graeme Eisenhofer

16 September 2023 in Archives of Computational Methods in Engineering
Verified
Journal Article
Open access
PDF file
SASandra Amador
Sandra Amador
FBFelix Beuschlein
Felix Beuschlein
VCVedant Chauhan
Vedant Chauhan
JFJudith Favier
Judith Favier
David GilDavid Gil
David Gil
AWAxel Walch
Axel Walch
Renal cancer is one of the ten most common cancers in the population that affects 65,000 new patients a year. Nowadays, to predict pathologies or classify tumors, deep learning (DL) methods are effective in addition to extracting high-performance features and dealing with segmentation tasks. This review has focused on the different studies related to the application of DL techniques for the detection or segmentation of renal tumors in patients. From the bibliographic search carried out, a total of 33 records were identified in Scopus, PubMed and Web of Science. The results derived from the systematic review give a detailed description of the research objectives, the types of images used for analysis, the data sets used, whether the database used is public or private, and the number of patients involved in the studies. The first paper where DL is applied compared to other types of tumors was in 2019 which is relatively recent. Public collection and sharing of data sets are of utmost importance to increase research in this field as many studies use private databases. We can conclude that future research will identify many benefits, such as unnecessary incisions for patients and more accurate diagnoses. As research in this field grows, the amount of open data is expected to increase.

8 February 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
ZWZhe Wang
Zhe Wang
ASAnthony Stell
Anthony Stell
RSRichard Sinnott
Richard Sinnott
TGthe ADDN Study Group
the ADDN Study Group
Australia has a high prevalence of diabetes, with approximately 1.2 million Australians diagnosed with the disease. In 2012, the Australasian Diabetes Data Network (ADDN) was established with funding from the Juvenile Diabetes Research Foundation (JDRF). ADDN is a national diabetes registry which captures longitudinal information about patients with type-1 diabetes (T1D). Currently, the ADDN data are directly contributed from 42 paediatric and 17 adult diabetes centres across Australia and New Zealand, i.e., where the data are pre-existing in hospital systems and not manually entered into ADDN. The historical data in ADDN have been de-identified, and patients are initially afforded the opportunity to opt-out of being involved in the registry; however, moving forward, there is an increased demand from the clinical research community to utilise fully identifying data. This raises additional demands on the registry in terms of security, privacy, and the nature of patient consent. General Data Protection Regulation (GDPR) is an increasingly important mechanism allowing individuals to have the right to know about their health data and what those data are being used for. This paper presents a mobile application being designed to support the ADDN data collection and usage processes and aligning them with GDPR. The app utilises Dynamic Consent—an informed specific consent model, which allows participants to view and modify their research-driven consent decisions through an interactive interface. It focuses specifically on supporting dynamic opt-in consent to both the registry and to associated sub-projects requesting access to and use of the patient data for research purposes.

29 January 2008
Verified
Conference Paper
Open access
PDF file
OAOluwafemi Ajayi
Oluwafemi Ajayi
RSRichard Sinnott
Richard Sinnott
ASAnthony Stell
Anthony Stell
© ACM, 2008. This is the author's version of the work. It is posted here by permission of ACM for your personal use. Not for redistribution. The definitive version was published in Proceedings of the 15th ACM Mardi Gras conference: From lightweight mash-ups to lambda grids: Understanding the spectrum of distributed computing requirements, applications, tools, infrastructures, interoperability, and the incremental adoption of key capabilities, 320, (2008) http://doi.acm.org/10.1145/1341811.1341821Security issues have always limited the way we do things. In an organisation we provide security by granting privileges to either identities or roles. However this becomes more challenging when the objective is collaboration across organisational boundaries. Numerous access control approaches exist today to address the cross-boundary control issues. However an optimal approach would be to fold remote security credentials into local security credentials, thereby bridging the gap that makes decentralised security policies for multi-domain collaboration difficult. In this paper, dynamic trust negotiation is presented as a possible optimal approach that provides support for decentralised access control. We show how trust pathways can be established and how remote security credentials could be folded to local security credentials through trust contracts.January 29-February 3Open Acces

1 October 2013
Verified
Conference Paper
Closed access
ASAnthony Stell
Anthony Stell
RSRichard Sinnott
Richard Sinnott
Breakthroughs in biomedicine are driven by research. More often than not, research takes place outside of a healthcare setting. However access to and use of clinical data for research purposes has many challenges that must be overcome, not least of which are the lack of standardized nomenclature and the heterogeneity of healthcare IT systems. For rare conditions, this challenge is particularly acute since the scarcity of data makes scientific breakthroughs increasingly difficult. Adrenal tumours represent one rare disease area where consolidation of clinical and biological information is urgently required. This paper describes the lessons being learnt in the development and rollout of an advanced security-oriented, virtual research environment (VRE) as part of the EU funded ENS@T-CANCER project. This system is currently used by 39 major cancer research centres across Europe and provides a unique resource for adrenal cancer research, underpinning an expanding portfolio of major international clinical trials and studies.

1 January 2020
Verified
Conference Paper
Closed access
ASAnthony Stell
Anthony Stell
VCVedant Chauhan
Vedant Chauhan
RSRichard Sinnott
Richard Sinnott